
Resveratrol supplementation decreases blood glucose without changing the circulating CD14+CD16+ monocytes and inflammatory cytokines in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study
Keywords: سلول های تک هسته ای خون محیطی; Inflammation; Type 2 diabetes; CD14+CD16+ monocytes; Resveratrol; PBMC; Clinical trial; BMI; body mass index; CD14+CD16+; cluster of differentiation 14,16; FBS; fasting blood glucose; FITC; fluorescein isothiocyanate; HbA1c; glycated hemoglobin; HDL-C; hi